scholarly journals Studies on lymphocyte subsets for the differential diagnosis between non-A, non-B viral hepatitis and drug induced liver injury, and on the role of Ia positive cell in lymphocyte stimulation test.

Kanzo ◽  
1988 ◽  
Vol 29 (1) ◽  
pp. 1-6
Author(s):  
Kaname YOSHIZAWA ◽  
Koji YABU ◽  
Kazuyuki UEMURA ◽  
Kiyoshi FURUTA ◽  
Yukio GIBO ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Liver Injury ◽  
Viral Hepatitis ◽  
Lymphocyte Subsets ◽  
Stimulation Test ◽  
Lymphocyte Stimulation ◽  
Lymphocyte Stimulation Test ◽  
Drug Induced ◽  
Drug Induced Liver Injury

scholarly journals Diagnostic value of drug lymphocyte stimulation test and evaluation of diagnostic criteria for drug induced liver injury.

Kanzo ◽  
2001 ◽  
Vol 42 (9) ◽  
pp. 448-454 ◽  
Author(s):  
Masaaki WATANABE ◽  
Akitaka SHIBUYA ◽  
Akihiko SATOMICHI ◽  
Kouji ONO ◽  
Takeshi TSUCHIHASHI ◽  
...  
Keyword(s):  
Liver Injury ◽  
Diagnostic Criteria ◽  
Diagnostic Value ◽  
Stimulation Test ◽  
Lymphocyte Stimulation ◽  
Lymphocyte Stimulation Test ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Test And Evaluation ◽  
Drug Lymphocyte Stimulation Test

scholarly journals The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development

2020 ◽  
Vol 94 (8) ◽  
pp. 2559-2585 ◽  
Author(s):  
Paul A. Walker ◽  
Stephanie Ryder ◽  
Andrea Lavado ◽  
Clive Dilworth ◽  
Robert J. Riley
Keyword(s):  
Drug Discovery ◽  
Liver Injury ◽  
Drug Uptake ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
New Chemical Entities ◽  
Preclinical Animal Models ◽  
Uptake Transporters

Abstract Early identification of toxicity associated with new chemical entities (NCEs) is critical in preventing late-stage drug development attrition. Liver injury remains a leading cause of drug failures in clinical trials and post-approval withdrawals reflecting the poor translation between traditional preclinical animal models and human clinical outcomes. For this reason, preclinical strategies have evolved over recent years to incorporate more sophisticated human in vitro cell-based models with multi-parametric endpoints. This review aims to highlight the evolution of the strategies adopted to improve human hepatotoxicity prediction in drug discovery and compares/contrasts these with recent activities in our lab. The key role of human exposure and hepatic drug uptake transporters (e.g. OATPs, OAT2) is also elaborated.

scholarly journals Role of autophagy in drug induced liver injury

2020 ◽  
Vol 94 (10) ◽  
pp. 3599-3600
Author(s):  
Tim Brecklinghaus
Keyword(s):  
Liver Injury ◽  
Drug Induced ◽  
Drug Induced Liver Injury
Sign in / Sign up

Export Citation Format

Share Document